Literature DB >> 7687739

Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.

G Yan1, Y Fukabori, G McBride, S Nikolaropolous, W L McKeehan.   

Abstract

Stroma and the heparin-binding fibroblast growth factor (FGF) family influence normal epithelial cell growth and differentiation in embryonic and adult tissues. The role of stromal cells and the expression of isoforms of the FGF ligand and receptor family were examined during malignant progression of epithelial cells from a differentiated, slowly growing, nonmalignant model rat prostate tumor. In syngeneic hosts, a mixture of stromal and epithelial cells resulted in nonmalignant tumors which were differentiated and slowly growing. In the absence of the stromal cells, epithelial cells progressed to malignant tumors which were independent of the stroma and undifferentiated. The independence of the malignant epithelial cells from stromal cells was accompanied by a switch from exclusive expression of exon IIIb to exclusive expression of exon IIIc in the FGF receptor 2 (FGF-R2) gene. The FGF-R2(IIIb) isoform displays high affinity for stromal cell-derived FGF-7, whereas the FGF-R2(IIIc) isoform does not recognize FGF-7 but has high affinity for the FGF-2 member of the FGF ligand family. The switch from expression of exclusively exon IIIb to exclusively exon IIIc in the resident FGF-R2 gene was followed by activation of the FGF-2 ligand gene, the normally stromal cell FGF-R1 gene, and embryonic FGF-3 and FGF-5 ligand genes in malignant epithelial cells. Multiple autocrine and potentially intracrine ligand-receptor loops resulting from these alterations within the FGF-FGF-R family may underlie the autonomy of malignant tumor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687739      PMCID: PMC360063          DOI: 10.1128/mcb.13.8.4513-4522.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

2.  Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors.

Authors:  P E Mansson; P Adams; M Kan; W L McKeehan
Journal:  Cancer Res       Date:  1989-05-01       Impact factor: 12.701

3.  Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta.

Authors:  W L McKeehan; P S Adams
Journal:  In Vitro Cell Dev Biol       Date:  1988-03

4.  The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors.

Authors:  X Zhan; B Bates; X G Hu; M Goldfarb
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma.

Authors:  L M Franks; P N Riddle; A W Carbonell; G O Gey
Journal:  J Pathol       Date:  1970-02       Impact factor: 7.996

Review 6.  Development and characteristics of the available animal model systems for the study of prostatic cancer.

Authors:  J T Isaacs
Journal:  Prog Clin Biol Res       Date:  1987

Review 7.  The endocrinology and developmental biology of the prostate.

Authors:  G R Cunha; A A Donjacour; P S Cooke; S Mee; R M Bigsby; S J Higgins; Y Sugimura
Journal:  Endocr Rev       Date:  1987-08       Impact factor: 19.871

8.  Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture.

Authors:  W L McKeehan; P S Adams; M P Rosser
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

9.  Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.

Authors:  J T Isaacs; W D Heston; R M Weissman; D S Coffey
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

10.  Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma.

Authors:  N Hayashi; G R Cunha; Y C Wong
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

View more
  111 in total

1.  Directional specificity of prostate stromal to epithelial cell communication via FGF7/FGFR2 is set by cell- and FGFR2 isoform-specific heparan sulfate.

Authors:  M Kan; F Uematsu; X Wu; F Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

Review 2.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

3.  Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.

Authors:  Teresa D Elo; Eeva M Valve; Jani A Seppänen; Heikki J Vuorikoski; Sari I Mäkelä; Matti Poutanen; Paula M Kujala; Pirkko L Härkönen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

4.  Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.

Authors:  T A Tetzke; M C Caton; P A Maher; Z Parandoosh
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

5.  Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Authors:  Emily A Newman; Stephanie J Muh; Ruben H Hovhannisyan; Claude C Warzecha; Richard B Jones; Wallace L McKeehan; Russ P Carstens
Journal:  RNA       Date:  2006-04-07       Impact factor: 4.942

6.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

7.  Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain.

Authors:  M K Webster; D J Donoghue
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

8.  FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Giovanna Tosato
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

Review 9.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

10.  Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells.

Authors:  P Savagner; A M Vallés; J Jouanneau; K M Yamada; J P Thiery
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.